151 related articles for article (PubMed ID: 35192686)
1. Lasting shift in the gut microbiota in patients with acute myeloid leukemia.
Rashidi A; Ebadi M; Rehman TU; Elhusseini H; Halaweish HF; Kaiser T; Holtan SG; Khoruts A; Weisdorf DJ; Staley C
Blood Adv; 2022 Jun; 6(11):3451-3457. PubMed ID: 35192686
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patients.
Malard F; Vekhoff A; Lapusan S; Isnard F; D'incan-Corda E; Rey J; Saillard C; Thomas X; Ducastelle-Lepretre S; Paubelle E; Larcher MV; Rocher C; Recher C; Tavitian S; Bertoli S; Michallet AS; Gilis L; Peterlin P; Chevallier P; Nguyen S; Plantamura E; Boucinha L; Gasc C; Michallet M; Dore J; Legrand O; Mohty M
Nat Commun; 2021 May; 12(1):3084. PubMed ID: 34035290
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota alterations induced by intensive chemotherapy in acute myeloid leukaemia patients are associated with gut barrier dysfunction and body weight loss.
Pötgens SA; Lecop S; Havelange V; Li F; Neyrinck AM; Neveux N; Maertens J; Walter J; Schoemans H; Delzenne NM; Bindels LB
Clin Nutr; 2023 Nov; 42(11):2214-2228. PubMed ID: 37806074
[TBL] [Abstract][Full Text] [Related]
4. Gut Microbiome Signatures Are Predictive of Infectious Risk Following Induction Therapy for Acute Myeloid Leukemia.
Galloway-Peña JR; Shi Y; Peterson CB; Sahasrabhojane P; Gopalakrishnan V; Brumlow CE; Daver NG; Alfayez M; Boddu PC; Khan MAW; Wargo JA; Do KA; Jenq RR; Kontoyiannis DP; Shelburne SA
Clin Infect Dis; 2020 Jun; 71(1):63-71. PubMed ID: 31436833
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota profiles of treatment-naïve adult acute myeloid leukemia patients with neutropenic fever during intensive chemotherapy.
Rattanathammethee T; Tuitemwong P; Thiennimitr P; Sarichai P; Na Pombejra S; Piriyakhuntorn P; Hantrakool S; Chai-Adisaksopha C; Rattarittamrong E; Tantiworawit A; Norasetthada L
PLoS One; 2020; 15(10):e0236460. PubMed ID: 33112882
[TBL] [Abstract][Full Text] [Related]
6. Oral and Stool Microbiome Coalescence and Its Association With Antibiotic Exposure in Acute Leukemia Patients.
Franklin S; Aitken SL; Shi Y; Sahasrabhojane PV; Robinson S; Peterson CB; Daver N; Ajami NA; Kontoyiannis DP; Shelburne SA; Galloway-Peña J
Front Cell Infect Microbiol; 2022; 12():848580. PubMed ID: 35433514
[TBL] [Abstract][Full Text] [Related]
7. Contribution of the Oral and Gastrointestinal Microbiomes to Bloodstream Infections in Leukemia Patients.
McMahon S; Sahasrabhojane P; Kim J; Franklin S; Chang CC; Jenq RR; Hillhouse AE; Shelburne SA; Galloway-Peña J
Microbiol Spectr; 2023 Jun; 11(3):e0041523. PubMed ID: 37022173
[TBL] [Abstract][Full Text] [Related]
8. The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia.
Galloway-Peña JR; Smith DP; Sahasrabhojane P; Ajami NJ; Wadsworth WD; Daver NG; Chemaly RF; Marsh L; Ghantoji SS; Pemmaraju N; Garcia-Manero G; Rezvani K; Alousi AM; Wargo JA; Shpall EJ; Futreal PA; Guindani M; Petrosino JF; Kontoyiannis DP; Shelburne SA
Cancer; 2016 Jul; 122(14):2186-96. PubMed ID: 27142181
[TBL] [Abstract][Full Text] [Related]
9. Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients.
Galloway-Peña JR; Smith DP; Sahasrabhojane P; Wadsworth WD; Fellman BM; Ajami NJ; Shpall EJ; Daver N; Guindani M; Petrosino JF; Kontoyiannis DP; Shelburne SA
Genome Med; 2017 Feb; 9(1):21. PubMed ID: 28245856
[TBL] [Abstract][Full Text] [Related]
10. Impact and consequences of intensive chemotherapy on intestinal barrier and microbiota in acute myeloid leukemia: the role of mucosal strengthening.
Hueso T; Ekpe K; Mayeur C; Gatse A; Joncquel-Chevallier Curt M; Gricourt G; Rodriguez C; Burdet C; Ulmann G; Neut C; Amini SE; Lepage P; Raynard B; Willekens C; Micol JB; De Botton S; Yakoub-Agha I; Gottrand F; Desseyn JL; Thomas M; Woerther PL; Seguy D
Gut Microbes; 2020 Nov; 12(1):1800897. PubMed ID: 32893715
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota regulates acute myeloid leukaemia via alteration of intestinal barrier function mediated by butyrate.
Wang R; Yang X; Liu J; Zhong F; Zhang C; Chen Y; Sun T; Ji C; Ma D
Nat Commun; 2022 May; 13(1):2522. PubMed ID: 35534496
[TBL] [Abstract][Full Text] [Related]
12. Altered microbiota-host metabolic cross talk preceding neutropenic fever in patients with acute leukemia.
Rashidi A; Ebadi M; Rehman TU; Elhusseini H; Nalluri H; Kaiser T; Ramamoorthy S; Holtan SG; Khoruts A; Weisdorf DJ; Staley C
Blood Adv; 2021 Oct; 5(20):3937-3950. PubMed ID: 34478486
[TBL] [Abstract][Full Text] [Related]
13. Dysbiosis patterns during re-induction/salvage versus induction chemotherapy for acute leukemia.
Rashidi A; Kaiser T; Shields-Cutler R; Graiziger C; Holtan SG; Rehman TU; Wasko J; Weisdorf DJ; Dunny G; Khoruts A; Staley C
Sci Rep; 2019 Apr; 9(1):6083. PubMed ID: 30988420
[TBL] [Abstract][Full Text] [Related]
14. Compilation of longitudinal gut microbiome, serum metabolome, and clinical data in acute myeloid leukemia.
Rashidi A; Ebadi M; Rehman TU; Elhusseini H; Halaweish H; Kaiser T; Holtan SG; Khoruts A; Weisdorf DJ; Staley C
Sci Data; 2022 Aug; 9(1):468. PubMed ID: 35918343
[TBL] [Abstract][Full Text] [Related]
15. Observational Cohort Study of Oral Mycobiome and Interkingdom Interactions over the Course of Induction Therapy for Leukemia.
Robinson S; Peterson CB; Sahasrabhojane P; Ajami NJ; Shelburne SA; Kontoyiannis DP; Galloway-Peña JR
mSphere; 2020 Apr; 5(2):. PubMed ID: 32295867
[TBL] [Abstract][Full Text] [Related]
16. Resource Utilization and Safety of Outpatient Management Following Intensive Induction or Salvage Chemotherapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Nonrandomized Clinical Comparative Analysis.
Vaughn JE; Othus M; Powell MA; Gardner KM; Rizzuto DL; Hendrie PC; Becker PS; Pottinger PS; Estey EH; Walter RB
JAMA Oncol; 2015 Nov; 1(8):1120-7. PubMed ID: 26355382
[TBL] [Abstract][Full Text] [Related]
17. Effect of COVID-19 precautions on the gut microbiota and nosocomial infections.
Rashidi A; Ebadi M; Rehman TU; Elhusseini H; Nalluri H; Kaiser T; Holtan SG; Khoruts A; Weisdorf DJ; Staley C
Gut Microbes; 2021; 13(1):1-10. PubMed ID: 34132630
[TBL] [Abstract][Full Text] [Related]
18. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
19. Impact of Amoxicillin-Clavulanate followed by Autologous Fecal Microbiota Transplantation on Fecal Microbiome Structure and Metabolic Potential.
Bulow C; Langdon A; Hink T; Wallace M; Reske KA; Patel S; Sun X; Seiler S; Jones S; Kwon JH; Burnham CA; Dantas G; Dubberke ER
mSphere; 2018 Nov; 3(6):. PubMed ID: 30463925
[TBL] [Abstract][Full Text] [Related]
20. Impact of induction chemotherapy with intermediate-dosed cytarabine and subsequent allogeneic stem cell transplantation on the outcome of high-risk acute myeloid leukemia.
Fleischmann M; Schnetzke U; Frietsch JJ; Sayer HG; Schrenk K; Hammersen J; Glaser A; Hilgendorf I; Hochhaus A; Scholl S
J Cancer Res Clin Oncol; 2022 Jun; 148(6):1481-1492. PubMed ID: 34297206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
